Compared to Estimates, MetLife (MET) Q4 Earnings: A Look at Key Metrics

Zacks
06 Feb

MetLife (MET) reported $19.74 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 5.5%. EPS of $2.08 for the same period compares to $1.93 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $19.23 billion, representing a surprise of +2.65%. The company delivered an EPS surprise of -2.35%, with the consensus EPS estimate being $2.13.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Adjusted Revenue- Corporate & other- Net investment income: $126 million versus $91.17 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +28.6% change.
  • Adjusted Revenue- Corporate & other- Premiums: -$11 million versus the three-analyst average estimate of $15 million. The reported number represents a year-over-year change of +450%.
  • Adjusted Revenue- EMEA- Net investment income: $59 million versus the three-analyst average estimate of $56.51 million. The reported number represents a year-over-year change of +9.3%.
  • Adjusted Revenue- Latin America- Net investment income: $431 million versus $436.74 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -10.6% change.
  • Revenue- Premiums: $12.62 billion versus $12.08 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +7.1% change.
  • Revenue- Other Revenues: $641 million versus $635.59 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -2.9% change.
  • Revenue- Universal life and investment-type product policy fees: $1.22 billion compared to the $1.30 billion average estimate based on five analysts. The reported number represents a change of -1.9% year over year.
  • Revenue- Net investment income: $5.41 billion compared to the $5.21 billion average estimate based on five analysts. The reported number represents a change of +0.7% year over year.
  • Adjusted Revenue- Retirement & Income Solutions- Premiums: $3.46 billion versus the three-analyst average estimate of $2.20 billion. The reported number represents a year-over-year change of +26.5%.
  • Adjusted Revenue- Retirement & Income Solutions- Universal life and investment-type product policy fees: $99 million compared to the $99 million average estimate based on three analysts. The reported number represents a change of +22.2% year over year.
  • Adjusted Revenue- Retirement & Income Solutions- Net investment income: $2.14 billion versus $2.16 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +5.5% change.
  • Adjusted Revenue- Retirement & Income Solutions- Other Revenues: $61 million versus the three-analyst average estimate of $81.03 million. The reported number represents a year-over-year change of -7.6%.
View all Key Company Metrics for MetLife here>>>

Shares of MetLife have returned +3% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

MetLife, Inc. (MET) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10